Martin A Mattingly - Net Worth and Insider Trading
Martin A Mattingly Net Worth
The estimated net worth of Martin A Mattingly is at least $0 dollars as of 2024-09-20. Martin A Mattingly is the Director of Achieve Life Sciences Inc and owns about 0 shares of Achieve Life Sciences Inc (ACHV) stock worth over $0. Details can be seen in Martin A Mattingly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martin A Mattingly has not made any transactions after 2012-06-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Martin A Mattingly
Martin A Mattingly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martin A Mattingly owns 2 companies in total, including TRACON Pharmaceuticals Inc (TCON) , and Achieve Life Sciences Inc (ACHV) .
Click here to see the complete history of Martin A Mattingly’s form 4 insider trades.
Insider Ownership Summary of Martin A Mattingly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2015-01-29 | director |
| ACHV | Achieve Life Sciences Inc | 2012-06-01 | director |
Martin A Mattingly Latest Holdings Summary
Martin A Mattingly currently owns a total of 1 stock. Martin A Mattingly owns 0 shares of Achieve Life Sciences Inc (ACHV) as of June 1, 2012, with a value of $0.
Latest Holdings of Martin A Mattingly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACHV | Achieve Life Sciences Inc | 2012-06-01 | 0 | 4.56 | 0 |
Holding Weightings of Martin A Mattingly
Martin A Mattingly Form 4 Trading Tracker
According to the SEC Form 4 filings, Martin A Mattingly has made a total of 0 transactions in Achieve Life Sciences Inc (ACHV) over the past 5 years. The most-recent trade in Achieve Life Sciences Inc is the acquisition of 0 shares on June 1, 2012, which cost Martin A Mattingly around $12,460.
Insider Trading History of Martin A Mattingly
- 1
Martin A Mattingly Trading Performance
GuruFocus tracks the stock performance after each of Martin A Mattingly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin A Mattingly is 5.31%. GuruFocus also compares Martin A Mattingly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin A Mattingly within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martin A Mattingly's insider trading performs compared to the benchmark.
Performance of Martin A Mattingly
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.38 | | | | | |
| Relative Return to S&P 500(%) | -3.2 | | | | | |
Martin A Mattingly Ownership Network
Martin A Mattingly Owned Company Details
What does TRACON Pharmaceuticals Inc do?
Who are the key executives at TRACON Pharmaceuticals Inc?
Martin A Mattingly is the director of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .
TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary
Over the past 18 months, Martin A Mattingly made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. , and a net purchase of 50,999 shares made by Charles Theuer .
In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 2,550 shares were bought by its insiders, resulting in a net sale of 235,650 shares.
TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.
TRACON Pharmaceuticals Inc Insider Transactions
Martin A Mattingly Mailing Address
Above is the net worth, insider trading, and ownership report for Martin A Mattingly. You might contact Martin A Mattingly via mailing address: C/o Trimeris, Inc., 2530 Meridian Parkway, 2nd Floor, Durham Nc 27713.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
